Table 1.
Clozapine Use | |||||
---|---|---|---|---|---|
Characteristic | No, N = 1207a | Yes, N = 191a | T/ | p-valueb | q-valuec |
Age at first service contact | 21.91 (3.41) | 20.27 (3.30) | 6.4 | <0.001 | <0.001 |
Sex | 0.10 | 0.8 | 0.8 | ||
Male | 617 (51%) | 100 (52%) | |||
Female | 590 (49%) | 91 (48%) | |||
Years of education | 10.82 (2.39) | 10.14 (2.19) | 3.9 | <0.001 | <0.001 |
Diagnosis | 39 | <0.001 | <0.001 | ||
Schizophrenia | 775 (64%) | 166 (87%) | |||
Other diagnoses of psychotic disorders | 432 (36%) | 25 (13%) | |||
Age of illness onset | 20.76 (3.47) | 19.26 (3.38) | 5.7 | <0.001 | <0.001 |
Treatment | 3.8 | 0.052 | 0.072 | ||
Early Intervention | 616 (51%) | 83 (43%) | |||
Standard Care | 591 (49%) | 108 (57%) | |||
DUP days (log) | 4.13 (1.87) | 4.25 (1.60) | −0.93 | 0.4 | 0.4 |
aMean (SD); n (%).
bWelch Two Sample t-test; Pearson’s Chi-squared test.
cFalse discovery rate correction for multiple testing.
The bold values are significant value after the false discovery rate correction for multiple testing.